ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Internal Medicine

Top Internal Medicine Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HENRY CHEN M.D

Internal Medicine

53,410

$6.39M

1671
1516 are 65+

1%
patients receiving schedule two controlled substances

Avg: 4%

2%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 30%

$120
Average prescription price

Avg: $69

JAVID YADEGAR MD

Internal Medicine

49,992

$3.44M

1037
855 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 30%

$69
Average prescription price

Avg: $69

JEFFREY AMIDON D.O.

Internal Medicine

48,916

$2.97M

1274
1047 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 30%

$61
Average prescription price

Avg: $69

SIXTO CARO

Internal Medicine

48,379

$3.59M

1085
853 are 65+

1%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 30%

$74
Average prescription price

Avg: $69

GEORGE HALL MD

Internal Medicine

46,714

$4.35M

1477
1269 are 65+

1%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 30%

$93
Average prescription price

Avg: $69

CHING-YIN LAM M.D.

Internal Medicine

38,893

$3.37M

999
957 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 30%

$87
Average prescription price

Avg: $69

FAISAL WASEEM M.D

Internal Medicine

38,564

$2.03M

926
784 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 30%

$53
Average prescription price

Avg: $69

CHANG LEE M.D.

Internal Medicine

38,306

$3.16M

1205
1098 are 65+

1%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 30%

$83
Average prescription price

Avg: $69

XIAORONG HE M.D.

Internal Medicine

36,498

$3.88M

884
823 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

34%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 30%

$106
Average prescription price

Avg: $69

BHASKAR YETURU MD

Internal Medicine

36,398

$2M

719
573 are 65+

23%
patients receiving schedule two controlled substances

Avg: 4%

2%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 30%

$55
Average prescription price

Avg: $69

HILLARY HURTADO MD

Internal Medicine

35,673

$1.98M

1000
811 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

1%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 30%

$56
Average prescription price

Avg: $69

DUSTIN NGUYEN MD

Internal Medicine

34,822

$4.51M

561
501 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 30%

$130
Average prescription price

Avg: $69

HARNATH CLERK MD

Internal Medicine

33,995

$1.76M

1100
823 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 30%

$52
Average prescription price

Avg: $69

BORIS PEYSIN M.D.

Internal Medicine

33,444

$2.37M

622
589 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 30%

$71
Average prescription price

Avg: $69

UMAMAHESWARA VEJENDLA M.D.

Internal Medicine

33,382

$2.24M

1268
1038 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 30%

$67
Average prescription price

Avg: $69

YEVGENIA ZINGER MD

Internal Medicine

33,263

$2.71M

539
505 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 30%

$81
Average prescription price

Avg: $69

RAMON DELMONTE MD

Internal Medicine

32,824

$1.59M

939
736 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

1%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 30%

$48
Average prescription price

Avg: $69

KLAUDIYA RUVINSKY M.D.

Internal Medicine

32,366

$3M

540
492 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

59%
prescriptions for brand name drugs

Avg: 30%

$93
Average prescription price

Avg: $69

YURY ZAMDBORG MD

Internal Medicine

32,351

$2.37M

578
522 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 30%

$73
Average prescription price

Avg: $69

BORIS KHORETS M.D.

Internal Medicine

32,051

$2.95M

969
864 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 30%

$92
Average prescription price

Avg: $69

ALEKSANDR LIVSHITS M.D.

Internal Medicine

32,045

$3.21M

604
547 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 30%

$100
Average prescription price

Avg: $69

ALEKSANDR ZASYPKIN MD

Internal Medicine

31,431

$2.75M

459
404 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 30%

$88
Average prescription price

Avg: $69

THOMAS MADEJSKI MD

Internal Medicine

30,924

$1.86M

1229
970 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 30%

$60
Average prescription price

Avg: $69

JIAN WEI ZHANG M.D.

Internal Medicine

29,959

$3.25M

1435
1248 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

2%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 30%

$108
Average prescription price

Avg: $69

VALERI KAZAKOV MD

Internal Medicine

29,911

$3.26M

531
479 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

23%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 30%

$109
Average prescription price

Avg: $69

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank